INC Research, a therapeutically focused global CRO, has attained four new accreditations in the Medidata Clinical Cloud. With accreditations in Medidata Designer, Medidata Grants Manager, Medidata CTMS and Medidata Rave Safety Gateway, INC Research is the first company to achieve all available accreditations in the Medidata platform.

 “By leveraging Medidata’s cloud-based clinical research platform along with our own Trusted Process methodology, INC can deliver time and cost-efficient methods that accelerate clinical development and optimize trials of every scope and scale from protocol design all the way through to database lock,” said Alistair Macdonald, chief operating officer.

INC Research is combining its therapeutic and operational knowledge to ensure each protocol drives efficiencies and reduces associated drug development costs. The company delivers site payments and monitors visit reporting, while offering visibility into trial milestones. Using the Medidata Rave Safety Gateway, INC Research can now automate sponsors’ EDC-to-safety-system data transfers to expedite case triage, improving the accuracy of serious adverse event (SAE) case data and reducing data reconciliation activities to eliminate error-prone phone, paper and fax processes.

In 2006, INC Research joined the Medidata Partner Program. The company achieved its first Medidata accreditation in 2007 for Medidata Rave, an electronic data capture (EDC) and clinical data management (CDM) system, and has conducted more than 160 study-builds using this tool. In May 2012, INC attained three additional accreditations, including Medidata Balance, RaveTargeted SDV and Medidata Coder.